QUANTA, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-08-17: Form 8-K; Period of report 2022-08-16; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2022-06-27: Form 8-K; Period of report 2022-06-24; Description 8.01 Other Events; Details 8.01.
- 2022-06-16: Form 8-K; Period of report 2022-06-16; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2022-05-04: Form 8-K; Period of report 2022-05-04; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2022-08-17 | 8-K | 2022-08-16 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On August 4, 2022 Quanta Inc. (the “Company”) received a letter of resignation from Grassi & Co. Certified Public Accountants, P.C. (“Grassi”) resigning and terminating its engagement as the Company’s independent registered public accounting firm. | form8-k.htm |
| 2022-06-27 | 8-K | 2022-06-24 | 8.01 Other Events | 8.01 On May 27, 2022, Quanta Inc. (the “Company”) received a Wells notice (the “Notice”) from the staff of the Los Angeles Regional Office of the Securities and Exchange Commission (the “Commission”) stating that they are recommending an enforcement action be filed against us based on (i) our financial statements and other information contained in reports filed by us with the Commission by us for our 2021 year and thereafter; and (ii) press releases issued by the Company. | form8-k.htm |
| 2022-06-16 | 8-K | 2022-06-16 | 1.01 Entry into a Material Definitive Agreement | 1.01 On November 12, 2021, Quanta, Inc., a Nevada corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Trillium Partners, L.P., a Delaware limited partnership (the “Investor”) pursuant to which the Investor purchased a convertible note in the principal amount of $82,500 (the “Note”) and a Warrant to purchase Common Stock of the Company in favor of Investor exercisable into 8,250,000 shares of Common Stock (the “Warrant”). | form8-k.htm |
| 2022-05-04 | 8-K | 2022-05-04 | 7.01 Regulation FD Disclosure | 7.01 On May 4, 2022, Quanta, Inc. (the “Company”) issued a press release announcing that it will hold a conference call on Thursday, May 12, 2022 at 5:00 PM Eastern Standard Time. | form8-k.htm |
| 2022-04-28 | 8-K | 2022-04-25 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On April 18, 2022, Quanta Inc. (the “Company”) received a letter of resignation from its principal independent accountant, Weinberg & Company, P.A. (“Weinberg”), terminating its engagement with the Company, which resignation was effective immediately. | form8-k.htm |
| 2021-11-19 | 8-K | 2021-11-19 | 7.01 Regulation FD Disclosure | 7.01 On November 19, 2021, Quanta, Inc. (the “Company”) issued a press release announcing that it will hold a conference call on Tuesday, November 23, 2021 at 5:00 PM Eastern Standard Time. | form8-k.htm |
| 2021-09-29 | 8-K/A | 2021-06-30 | 1.01 Entry into a Material Definitive Agreement | 1.01 On July 2, 2021, Quanta, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Filing”) to report that the Company had entered into a consulting and advisory agreement (the “Agreement”) with Eden Capital, LLC. | form8-ka.htm |
| 2021-08-24 | 8-K | 2021-08-23 | 2.02 Results of Operations and Financial Condition | 2.02 On August 24, 2021, Quanta, Inc. (the “Company”) will hold a conference call at 5:00 p.m. | form8-k.htm |
| 2021-07-29 | 8-K | 2021-07-29 | 8.01 Other Events | 8.01 On June 21, 2021, Quanta, Inc. (the “Company”) filed Form DEF-14C with the Securities and Exchange Commission, wherein notice was given to its shareholders of certain corporate actions that had been taken by written consent of stockholders in lieu of a special meeting of the stockholders. | form8-k.htm |
| 2021-07-02 | 8-K | 2021-06-30 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 5.02 On June 30, 2021 Grant Mikaelian and Pauline Ranjbar accepted appointments to the Company’s board of directors. 8.01 On July 1, 2021, the Company filed an application for the OTCQB Venture Market. | form8-k.htm |
| 2021-05-11 | 8-K | 2021-05-10 | 1.01 Entry into a Material Definitive Agreement; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.01 As discussed in Item 1.01 above, the May 10, 2021 Control Block Transfer Agreement represents a change in majority voting control of the Company, since Arthur Mikaelian now holds the Control Block, entitling him to 51% majority voting control on all matters coming before a vote of our shareholders. 5.02 On May 10, 2021, in connection with the execution of the Control Block Transfer Agreement, Phil Sands submitted his resignation from all Officer and Director positions with the Company, which will be effective following the ten-day period after the mailing of a Schedule 14F to our shareholders of record, at which time our current CEO and Director, Dr. Mikaelian, shall assume the additional roles of President, CFO, Secretary and Treasurer of the Company until such time as others are appointed. | form8-k.htm |
| 2021-01-19 | 8-K | 2021-01-12 | 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3.02 As previously reported in the Current Report on Form 8-K filed on December 22, 2020, and in the Schedule 14F filed on December 30, 2020, the Board of Directors of QUANTA, INC. 5.02 On December 21, 2020, Dr. Mikaelian was also appointed to serve as the Company’s Chief Executive Officer, a role which he assumed on January 14, 2021. 5.03 On January 12, 2021, the Company filed Certificates of Designation establishing the designations, preferences, limitations and relative rights of the Company’s Series B Convertible Preferred Stock and Series C Convertible Preferred Stock in the State of Nevada. | form8-k.htm |
| 2020-12-22 | 8-K | 2020-12-21 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 On December 21, 2020, in connection with the entry into the Securities Exchange Agreement with Medolife Rx, Inc., Arthur G. Mikaelian, Ph.D was appointed as a member of the Board of Directors of Quanta, Inc. Dr. Mikaelian joins Phil Sands on our Board, and Mr. Sands continues to serve as the Company’s President and Director. | form8-k.htm |
| 2020-11-18 | 8-K | 2020-11-13 | 1.01 Entry into a Material Definitive Agreement; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.01 As discussed in Item 1.01 above, the November 16, 2020 Control Block Transfer Agreement represents a change in majority voting control of the Company, since Phil Sands now holds the Control Block, entitling him to 51% majority voting control on all matters coming before a vote of our shareholders. 5.02 On November 13, 2020, and in connection with the Transition to a Holding Company, Mr. Phil Sands was appointed to serve as our new Chief Executive Officer, a role which he will assume following the ten-day period after the mailing of a Schedule 14F to our shareholders of record, at which time Eric Rice shall resign from all officer and director positions with the Company. | form8-k.htm |
| 2020-11-13 | 8-K | 2020-11-13 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On November 13, 2020, Mr. Phil Sands was appointed as a member of the Board of Directors of Quanta, Inc. (the “Company”). | form8-k.htm |
| 2020-07-09 | 8-K | 2020-07-08 | 7.01 Regulation FD Disclosure | 7.01 On July 8, 2020, Quanta, Inc. (the “Company”, “we”, “us” or “our”) issued a press release disclosing that management of the Company will host a virtual town hall meeting on July 15, 2020 at 1:30 PM Eastern Time to provide updates on recent events at the Company, with Q&A to follow. | form8-k.htm |
| 2020-06-19 | 8-K | 2020-06-19 | 7.01 Regulation FD Disclosure | 7.01 On June 19, 2020, Quanta, Inc. (the “Company”, “we”, “us” or “our”) issued a press release announcing its first quarter 2020 results of operations and filing of its March 31, 2020 10-Q with the SEC, in compliance with the 45-day COVID-19 related extension period granted under SEC Section 36 of the Securities Act of 1934. | form8-k.htm |
| 2020-06-15 | 8-K | 2020-06-11 | 7.01 Regulation FD Disclosure | 7.01 On June 11, 2020, Quanta, Inc. (the “Company”, “we”, “us” or “our”) issued a press release disclosing that management of the Company will host a virtual town hall meeting on June 15, 2020 at 1:30 PM Eastern Time to provide updates on recent events at the Company, with Q&A to follow. | form8-k.htm |
| 2020-05-29 | 8-K | 2020-05-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On May 22, 2020, Quanta, Inc. (the “Company”, “we”, “us” or “our”), entered into stock option amendments with various employees to amend certain outstanding Company stock option grants awarded to such employees between October 2019 and December 2019 (collectively, the “Stock Options”) pursuant to the Company’s 2019 Omnibus Stock Incentive Plan. | form8-k.htm |
| 2020-05-20 | 8-K | 2020-05-20 | 7.01 Regulation FD Disclosure | 7.01 On May 20, 2020, Quanta, Inc. (the “Company”, “we”, “us” or “our”) issued a press release disclosing that management of the Company will host a virtual town hall meeting on May 21, 2020 at 1:30 PM Eastern Time to provide a shareholder update on recent events at the Company, with Q&A to follow. | form8-k.htm |
| 2020-05-14 | 8-K | 2020-05-14 | 8.01 Other Events | 8.01 Quanta, Inc. (the “Company”, “we”, “us” or “our”) is filing this Current Report on Form 8-K pursuant to the Order (the “SEC Order”) issued by the U.S. Securities and Exchange Commission (the “SEC”) on March 25, 2020 (Release No. 34-88465) providing conditional relief to public companies that are unable to timely comply with their filing obligations as a result of the novel coronavirus (COVID-19) outbreak. | form8-k.htm |
| 2020-05-01 | 8-K | 2020-04-27 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 2.03 The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. 3.02 The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. | form8-k.htm |
| 2020-04-14 | 8-K | 2020-04-14 | 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3.02 On April 14, 2020, Quanta, Inc. (the “Company”) issued to Eric Rice, its Chairman, Chief Executive Officer and Chief Financial Officer, 2,500,000 shares of a newly created class of preferred stock, Series A Preferred Stock (“Series A Preferred Stock”), in a private placement transaction in satisfaction of certain accrued compensation currently owed to Mr. Rice. 3.03 On April 14, 2020, the Company filed a Certificate of Designation for the Company’s Series A Preferred Stock with the Secretary of State of Nevada designating 2,500,000 shares of its authorized preferred stock as Series A Preferred Stock, par value of $0.001 per share. 5.03 The disclosure in Item 3.03 of this Current Report on Form 8-K regarding the Certificate of Designation is incorporated by reference into this Item. | form8-k.htm |
| 2020-04-14 | 8-K | 2020-04-14 | 7.01 Regulation FD Disclosure | 7.01 On April 14, 2020, Quanta, Inc. issued a press release regarding its results of operations and financial condition for the year ended December 31, 2019. | form8k.htm |
| 2020-04-10 | 8-K | 2020-03-26 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 2.03 The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. 3.02 The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. | form8-k.htm |
| 2019-11-26 | 8-K | 2019-11-25 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 2.03 The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. 3.02 The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item. | form8-k.htm |
| 2019-09-05 | 8-K | 2019-09-04 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On September 4, 2019, the Board of Directors (“Board”) of Quanta, Inc. (the “Company”) approved forms of employment agreements for each of Eric Rice, Jeffrey Doiron, Blake Gillette and Kirk Westwood (collectively, the “Employees”), and each of them entered into such agreements with the Company on the same date (collectively, the “Employment Agreements”). | form8-k.htm |
| 2019-06-27 | 8-K | 2019-06-27 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective June 27, 2019, the board of directors of Quanta, Inc. (the “Company”) adopted the Quanta, Inc. 2019 Omnibus Stock Incentive Plan (the “2019 Plan”). | form8-k.htm |
| 2019-02-15 | 8-K | 2019-02-15 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Dismissal of Independent Registered Public Accounting Firm. | form8-k.htm |
| 2019-01-25 | 8-K | 2018-12-31 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On December 31, 2018, the Board of Directors of Quanta, Inc. (the “Company”) adopted a resolution to change the Company’s fiscal year end from May 1 to December 31, effective immediately as of the date of the board resolution. | form8-k.htm |
| 2018-12-21 | 8-K/A | 2018-06-06 | 9.01 Financial Statements and Exhibits | form8ka.htm | |
| 2018-09-25 | 8-K | 2018-09-24 | 1.01 Entry into a Material Definitive Agreement | 1.01 On September 12, 2018, Quanta, Inc., a Nevada corporation (the “Registrant” or the “Company”) entered into a joint venture agreement (the “Joint Venture Agreement”) with 2664431 Ontario Inc. The purpose of the Joint Venture Agreement was to extend the Quanta brand, technology and product lines into the Canadian markets. | form8k.htm |
| 2018-07-30 | 8-K | 2018-07-27 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On July 26, 2018, PLS CPA, A Professional Corp. (“PLS CPA”) was dismissed as the independent registered public accounting firm of Freight Solution, Inc. (the “Company”). | f8k072718_8k.htm |
| 2018-06-18 | 8-K/A | 2018-06-06 | 9.01 Financial Statements and Exhibits | form8ka.htm | |
| 2018-06-18 | 8-K | 2018-06-06 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 1.01 On June 6, 2018, the Company executed the Merger Agreement. 2.01 As previously disclosed, effective June 6, 2018, Freight Solution, Inc., a Nevada corporation (the “Registrant” or the “Company”) consummated an Agreement of Merger and Plan of Reorganization (the “Merger Agreement”), with Bioanomaly, Inc., a California corporation d/b/a Quanta (“Quanta”) and Quanta Acquisition Corp., a California corporation and wholly-owned subsidiary of the Company (“Acquisition”). 3.02 As disclosed in Item 2.01, which disclosures are hereby incorporated by reference, in connection with the Merger, the Company issued an aggregate of 25,900,000 shares of its common stock to the shareholders of Quanta. 5.01 The disclosures set forth in Item 2.01 are hereby incorporated by reference into this Item 5.01. 5.02 The disclosures set forth in Item 2.01 are hereby incorporated by reference into this Item 5.02. 5.03 The disclosures set forth in Item 2.01 are hereby incorporated by reference to this Item 5.03. | form8k.htm |